학술논문

GSK3β Inhibition Ameliorates Atherosclerotic Calcification.
Document Type
Article
Source
International Journal of Molecular Sciences. Jul2023, Vol. 24 Issue 14, p11638. 8p.
Subject
*CALCIFICATION
*ARTERIAL calcification
*EXTRACELLULAR matrix proteins
*CATENINS
*GLYCOGEN
Language
ISSN
1661-6596
Abstract
Endothelial-mesenchymal transition (EndMT) drives endothelium to contribute to atherosclerotic calcification. In a previous study, we showed that glycogen synthase kinase-3β (GSK3β) inhibition induced β-catenin and reduced mothers against DPP homolog 1 (SMAD1) in order to redirect osteoblast-like cells towards endothelial lineage, thereby reducing vascular calcification in Matrix Gla Protein (Mgp) deficiency and diabetic Ins2Akita/wt mice. Here, we report that GSK3β inhibition or endothelial-specific deletion of GSK3β reduces atherosclerotic calcification. We also find that alterations in β-catenin and SMAD1 induced by GSK3β inhibition in the aortas of Apoe−/− mice are similar to Mgp−/− mice. Together, our results suggest that GSK3β inhibition reduces vascular calcification in atherosclerotic lesions through a similar mechanism to that in Mgp−/− mice. [ABSTRACT FROM AUTHOR]